View Financial HealthThe9 배당 및 자사주 매입배당 기준 점검 0/6The9 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-5.7%자사주 매입 수익률총 주주 수익률-5.7%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesBoard Change • May 21Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 5 highly experienced directors. CFO & Director George Lai was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공시 • Nov 13The9 Limited, Annual General Meeting, Dec 22, 2025The9 Limited, Annual General Meeting, Dec 22, 2025, at 14:00 China Standard Time. Location: bny mellon office, room no. 2602,26/f three pacific place, 1queens road east, wanchai., Hong Kong공시 • Sep 23The9 Limited Announces Impersonation of the9bit on A Crypto PlatformThe9 Limited announced to the9bit community and the wider public that accounts and token listings on a crypto platform are impersonating the9bit and claiming affiliation with the9bit. These accounts and tokens are unauthorized, fraudulent, and not connected to the9bit in any way. Please note: the9bit has not launched nor endorsed any tokens on any crypto exchange yet. Currently any listings, messages, or wallets claiming to represent the9bit are scams. Do not interact with, send funds to, or otherwise engage with these impersonating listings. What the9bit is doing to protect the community: the9bit has contacted that crypto platform's legal team and their support channels to report the impersonation and are actively working with them to determine what actions can be taken to remove the fraudulent listings and prevent further abuse. the9bit is monitoring the situation closely and will share updates through the official channels.공시 • Apr 01The9 Limited announced that it expects to receive $8 million in funding from Bripheno Pte. Ltd. and other investorsThe9 Limited announced that it has entered into a purchase agreement to issue class A common shares for the gross proceeds of $8 million on March 31, 2025. The shares issued are subject to statutory lock-up period. The transaction will include participation from Bripheno Pte. Ltd., Elune Capital, Fine Vision Fund.공시 • Nov 20The9 Limited, Annual General Meeting, Dec 27, 2024The9 Limited, Annual General Meeting, Dec 27, 2024, at 14:00 China Standard Time. Location: bny mellon office, room no. 4, 26/f three pacific place, 1 queen`s road east, hong kong, ChinaBoard Change • Jun 06Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 5 highly experienced directors. CFO & Director George Lai was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공시 • Jun 05The9 Limited (NasdaqCM:NCTY) agreed to acquire 19% stake in Wuhan Weixiang Science And Technology Co., Ltd for $ 8.16 million.The9 Limited (NasdaqCM:NCTY) signed a definitive share purchase agreement to acquire 19% stake in Wuhan Weixiang Science And Technology Co., Ltd for $8.16 million on June 3, 2024. The consideration consists of $1.5 million in cash and issuance of 948,218 ADSs.공시 • May 25The9 Limited announced that it expects to receive $3.5 million in funding from Finewill CapitalThe9 Limited announced a private placement of class A ordinary shares for the gross proceeds of $3.5 million on May 24, 2024. The transaction will include participation from new investor, Fine Vision Fund , a fund managed by, Finewill Capital. These shares to be issued are subject to the statutory lock-up period. The invetsor will invest with upfront investment of $2.5 million and second installment of $1 million which is based on a pre-agreed condition.공시 • May 21The9 Limited (NasdaqCM:NCTY) signed a definitive share purchase agreement to acquire 15% stake in Kuaijin Times (Xiamen) Technology Co.,Ltd.The9 Limited (NasdaqCM:NCTY) signed a definitive share purchase agreement to acquire 15% stake in Kuaijin Times (Xiamen) Technology Co.,Ltd. on May 20, 2024. Pursuant to the Agreement, The9 will pay cash consideration of $1.5 million and will issue 318,448,800 restricted Class A ordinary shares (equivalent to 1,061,496 ADSs) to KuaiJin, which will be subject to lock-up conditions. The9 is also granted a purchase option to purchase up to 51% of the total shares of KuaiJin. The purchase option is exercisable within 2 years and will be based on KuaiJin's valuation at $60 million.공시 • Mar 27The9 Limited (NasdaqCM:NCTY) entered into a definitive share purchase agreement to acquire additional 21.7% stake in WM Therapeutics Co., Ltd. for approximately $6.1 million.The9 Limited (NasdaqCM:NCTY) entered into a definitive share purchase agreement to acquire additional 21.7% stake in WM Therapeutics Co., Ltd. for approximately $6.1 million on March 26, 2024. The consideration includes cash consideration of $1.5 million and issuance of 251.3 million restricted Class A ordinary shares equivalent to 0.84 million ADSs. Prior to the transaction, The9 Limited (NasdaqCM:NCTY) held 8.3%. The9 is also granted a purchase option to purchase up to 51% of the total shares of WM Therapeutic under certain conditions.공시 • Feb 22The9 Limited signed an term sheet to acquire 19% stake in Zhejiang Fazhidao Information Technology Co., Ltd. for $15.6 million.The9 Limited signed an term sheet to acquire 19% stake in Zhejiang Fazhidao Information Technology Co., Ltd. for $15.6 million on February 21, 2024.공시 • Nov 30The9 Limited announced that it has received $12 million in funding from Bripheno Pte. Ltd.,The9 Limited announced that it has announced a private placement of 150,000,000 class A ordinary shares at a price of $0.04 per share for the gross proceeds $6 million and two-year 3% per annum convertible promissory note at a price of $6 million and warrants for the gross proceeds of $12 million on November 30, 2023. The notes will be convertible into American depository shares with the conversion price of $15 per share and warrants to purchase an aggregate of 120,000,000 class A ordinary shares at an exercise price of $60 per ADS. The warrants will expire two years from the date of issuance. The issued securities are subject to a 6-month lock up period. The transaction will include participation from new investor, Bripheno Pte. Ltd.,공시 • Nov 17The9 Limited, Annual General Meeting, Dec 22, 2023The9 Limited, Annual General Meeting, Dec 22, 2023, at 14:00 China Standard Time. Location: BNY Mellon Office, Room No. 2602, 26/F Three Pacific Place 1 Queen's Road East Wanchai Hong KongNew Risk • Oct 02New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 71% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 34% per year over the past 5 years. Shareholders have been substantially diluted in the past year (71% increase in shares outstanding).Reported Earnings • Dec 26First half 2022 earnings released: CN¥26.75 loss per share (vs CN¥11.19 loss in 1H 2021)First half 2022 results: CN¥26.75 loss per share (further deteriorated from CN¥11.19 loss in 1H 2021). Net loss: CN¥579.7m (loss widened 361% from 1H 2021). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 59% per year, which means it is significantly lagging earnings.공시 • Nov 18The9 Limited, Annual General Meeting, Dec 19, 2022The9 Limited, Annual General Meeting, Dec 19, 2022, at 14:00 China Standard Time. Location: 17 Floor, No. 130 Wu Song Road, Hong Kou District Shanghai ChinaBoard Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. CFO & Director George Lai was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • May 04Full year 2021 earnings releasedFull year 2021 results: Revenue: CN¥135.9m (up CN¥135.2m from FY 2020). Net loss: CN¥411.2m (down 204% from profit in FY 2020).Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. CFO & Director George Lai was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Apr 15Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. CFO & Director George Lai was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공시 • Jun 05The9 Limited (NasdaqCM:NCTY) signed a definitive agreement to acquire an unknown stake in Montcrypto Ltd.The9 Limited (NasdaqCM:NCTY) signed a definitive agreement to acquire an unknown stake in Montcrypto Ltd. on June 4, 2021. According to the agreement, The9 plans to invest a total of CAD 7.6 million in Montcrypto in two phases to obtain the controlling stake in Montcrypto. The9 will pay hosting fee to Montcrypto at a rate of CAD 0.037/kWh for a period of 5 years.공시 • Mar 10The9 Limited to Report Fiscal Year 2020 Results on Mar 29, 2021The9 Limited announced that they will report fiscal year 2020 results on Mar 29, 2021공시 • Feb 23The9 Limited (NasdaqCM:NCTY) entered into a binding memorandum of understanding to acquire 70% stake in Hangzhou SuanLi Technology Co., Ltd. for $7 million.The9 Limited (NasdaqCM:NCTY) entered into a binding memorandum of understanding to acquire 70% stake in Hangzhou SuanLi Technology Co., Ltd. for $7 million on February 22, 2021. The consideration will be paid by issuing Class A ordinary shares of The9 Limited, subject to due diligence and valuation to be conducted by an independent valuation firm.공시 • Feb 10The9 Limited Enters into a Standby Equity Distribution Agreement with YA II PN, LTDThe9 Limited announced that it has entered into a standby equity distribution agreement with YA II PN, LTD., dated February 5, 2021, pursuant to which The9 would be able to sell up to $100.0 million of its ADSs solely at The9’s request based on The9’s funding requirement at any time during the 36 months following the date of the SEDA.공시 • Nov 21The9 Limited, Annual General Meeting, Dec 22, 2020The9 Limited, Annual General Meeting, Dec 22, 2020, at 14:00 China Standard Time. Location: at the 17 Floor, No. 130 Wu Song Road, Hong Kou District Shanghai China공시 • Nov 18The9 Limited Announces Receipt of Nasdaq Notice of DeficiencyThe9 Limited announced on November 17, 2020 that it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market Inc. ("Nasdaq") dated November 12, 2020, indicating that the Company no longer meets the continued listing requirement of minimum Market Value of Listed Securities ("MVLS") for the Nasdaq Capital Market, as set forth in the Nasdaq Listing Rule 5550(b)(2) because the market value of the Company's securities listed on Nasdaq for the last 30 consecutive business days was below the minimum MVLS requirement of $35.0 million. Pursuant to the Rule 5810(c)(3)(C) of the Nasdaq Listing Rules, the Company has a compliance period of 180 calendar days, or until May 11, 2021 (the "Compliance Period"), to regain compliance with Nasdaq's minimum MVLS requirement. If at any time during the Compliance Period, the Company's MVLS closes at $35.0 million or more for a minimum of ten consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed. In the event the Company does not regain compliance with Rule 5550(b)(2) prior to the expiration of the Compliance Period, the Company will receive written notification that its securities are subject to delisting.공시 • Nov 05The9 Limited Regains Compliance with Nasdaq Listing RequirementThe9 Limited announced that it received a notification letter from the Nasdaq Stock Market LLC ("Nasdaq") on November 2, 2020 stating that The9 has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) and the matter is now closed.공시 • Oct 02The9 Limited has completed a Follow-on Equity Offering.The9 Limited has completed a Follow-on Equity Offering. Security Name: American Depositary Shares Security Type: Depositary Receipt (Common Stock) Securities Offered: 23,500,000 Price\Range: $0.37 Discount Per Security: $0.0259 Security Name: Warrants Security Type: Equity Warrant Securities Offered: 23,500,000공시 • Oct 01The9 Limited announced that it expects to receive $30 million in funding from Ark Pacific Capital Management Limited, IE LimitedThe9 Limited (NasdaqGS:NCTY) announced that it has entered into a term sheet for the private placement of 25,000,000 ordinary shares at a price of $1.2 per share for gross proceeds of $30,000,000 on April 10, 2017. The transaction will include participation from existing investor Ark Pacific Special Opportunities Fund I, L.P., a fund managed by Ark Pacific Capital Management Limited and IE Limited (KOSDAQ:A023430). Each investor will subscribe for 50% of the total shares. The shares will be subject to a redemption right. The completion of the each transaction is subject to the parties execution of a definitive agreement and customary closing conditions to be stipulated therein.공시 • Sep 22The9 Limited and Voodoo Sign Cooperation and Publishing AgreementThe9 Limited announced that it has signed an Agreement with Voodoo. The9 and Voodoo will collaborate on the publishing and operation of casual games in mainland China. The9 will publish and operate under this agreement two, with an option for a third, casual games with strong IAP (In App Purchase) licensed by Voodoo.공시 • Aug 07The9 Limited Regains Compliance with Nasdaq Listing RequirementThe9 Limited announced that it received a notification letter from the Nasdaq Stock Market LLC ("Nasdaq") on August 5, 2020 stating that The9 has regained compliance with the minimum market value of listed securities requirement under Nasdaq Listing Rule 5550(b)(2) and the matter is now closed.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 FZK0 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: FZK0 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장The9 배당 수익률 vs 시장FZK0의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (FZK0)n/a시장 하위 25% (DE)1.5%시장 상위 25% (DE)4.5%업계 평균 (Software)1.7%분석가 예측 (FZK0) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 FZK0 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 FZK0 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 FZK0 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: FZK0 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YDE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/21 04:55종가2026/05/21 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스The9 Limited는 8명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Eddie LeungBofA Global ResearchAlicia YapCitigroup IncDi WeiJ.P. Morgan5명의 분석가 더 보기
Board Change • May 21Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 5 highly experienced directors. CFO & Director George Lai was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공시 • Nov 13The9 Limited, Annual General Meeting, Dec 22, 2025The9 Limited, Annual General Meeting, Dec 22, 2025, at 14:00 China Standard Time. Location: bny mellon office, room no. 2602,26/f three pacific place, 1queens road east, wanchai., Hong Kong
공시 • Sep 23The9 Limited Announces Impersonation of the9bit on A Crypto PlatformThe9 Limited announced to the9bit community and the wider public that accounts and token listings on a crypto platform are impersonating the9bit and claiming affiliation with the9bit. These accounts and tokens are unauthorized, fraudulent, and not connected to the9bit in any way. Please note: the9bit has not launched nor endorsed any tokens on any crypto exchange yet. Currently any listings, messages, or wallets claiming to represent the9bit are scams. Do not interact with, send funds to, or otherwise engage with these impersonating listings. What the9bit is doing to protect the community: the9bit has contacted that crypto platform's legal team and their support channels to report the impersonation and are actively working with them to determine what actions can be taken to remove the fraudulent listings and prevent further abuse. the9bit is monitoring the situation closely and will share updates through the official channels.
공시 • Apr 01The9 Limited announced that it expects to receive $8 million in funding from Bripheno Pte. Ltd. and other investorsThe9 Limited announced that it has entered into a purchase agreement to issue class A common shares for the gross proceeds of $8 million on March 31, 2025. The shares issued are subject to statutory lock-up period. The transaction will include participation from Bripheno Pte. Ltd., Elune Capital, Fine Vision Fund.
공시 • Nov 20The9 Limited, Annual General Meeting, Dec 27, 2024The9 Limited, Annual General Meeting, Dec 27, 2024, at 14:00 China Standard Time. Location: bny mellon office, room no. 4, 26/f three pacific place, 1 queen`s road east, hong kong, China
Board Change • Jun 06Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 5 highly experienced directors. CFO & Director George Lai was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공시 • Jun 05The9 Limited (NasdaqCM:NCTY) agreed to acquire 19% stake in Wuhan Weixiang Science And Technology Co., Ltd for $ 8.16 million.The9 Limited (NasdaqCM:NCTY) signed a definitive share purchase agreement to acquire 19% stake in Wuhan Weixiang Science And Technology Co., Ltd for $8.16 million on June 3, 2024. The consideration consists of $1.5 million in cash and issuance of 948,218 ADSs.
공시 • May 25The9 Limited announced that it expects to receive $3.5 million in funding from Finewill CapitalThe9 Limited announced a private placement of class A ordinary shares for the gross proceeds of $3.5 million on May 24, 2024. The transaction will include participation from new investor, Fine Vision Fund , a fund managed by, Finewill Capital. These shares to be issued are subject to the statutory lock-up period. The invetsor will invest with upfront investment of $2.5 million and second installment of $1 million which is based on a pre-agreed condition.
공시 • May 21The9 Limited (NasdaqCM:NCTY) signed a definitive share purchase agreement to acquire 15% stake in Kuaijin Times (Xiamen) Technology Co.,Ltd.The9 Limited (NasdaqCM:NCTY) signed a definitive share purchase agreement to acquire 15% stake in Kuaijin Times (Xiamen) Technology Co.,Ltd. on May 20, 2024. Pursuant to the Agreement, The9 will pay cash consideration of $1.5 million and will issue 318,448,800 restricted Class A ordinary shares (equivalent to 1,061,496 ADSs) to KuaiJin, which will be subject to lock-up conditions. The9 is also granted a purchase option to purchase up to 51% of the total shares of KuaiJin. The purchase option is exercisable within 2 years and will be based on KuaiJin's valuation at $60 million.
공시 • Mar 27The9 Limited (NasdaqCM:NCTY) entered into a definitive share purchase agreement to acquire additional 21.7% stake in WM Therapeutics Co., Ltd. for approximately $6.1 million.The9 Limited (NasdaqCM:NCTY) entered into a definitive share purchase agreement to acquire additional 21.7% stake in WM Therapeutics Co., Ltd. for approximately $6.1 million on March 26, 2024. The consideration includes cash consideration of $1.5 million and issuance of 251.3 million restricted Class A ordinary shares equivalent to 0.84 million ADSs. Prior to the transaction, The9 Limited (NasdaqCM:NCTY) held 8.3%. The9 is also granted a purchase option to purchase up to 51% of the total shares of WM Therapeutic under certain conditions.
공시 • Feb 22The9 Limited signed an term sheet to acquire 19% stake in Zhejiang Fazhidao Information Technology Co., Ltd. for $15.6 million.The9 Limited signed an term sheet to acquire 19% stake in Zhejiang Fazhidao Information Technology Co., Ltd. for $15.6 million on February 21, 2024.
공시 • Nov 30The9 Limited announced that it has received $12 million in funding from Bripheno Pte. Ltd.,The9 Limited announced that it has announced a private placement of 150,000,000 class A ordinary shares at a price of $0.04 per share for the gross proceeds $6 million and two-year 3% per annum convertible promissory note at a price of $6 million and warrants for the gross proceeds of $12 million on November 30, 2023. The notes will be convertible into American depository shares with the conversion price of $15 per share and warrants to purchase an aggregate of 120,000,000 class A ordinary shares at an exercise price of $60 per ADS. The warrants will expire two years from the date of issuance. The issued securities are subject to a 6-month lock up period. The transaction will include participation from new investor, Bripheno Pte. Ltd.,
공시 • Nov 17The9 Limited, Annual General Meeting, Dec 22, 2023The9 Limited, Annual General Meeting, Dec 22, 2023, at 14:00 China Standard Time. Location: BNY Mellon Office, Room No. 2602, 26/F Three Pacific Place 1 Queen's Road East Wanchai Hong Kong
New Risk • Oct 02New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 71% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 34% per year over the past 5 years. Shareholders have been substantially diluted in the past year (71% increase in shares outstanding).
Reported Earnings • Dec 26First half 2022 earnings released: CN¥26.75 loss per share (vs CN¥11.19 loss in 1H 2021)First half 2022 results: CN¥26.75 loss per share (further deteriorated from CN¥11.19 loss in 1H 2021). Net loss: CN¥579.7m (loss widened 361% from 1H 2021). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 59% per year, which means it is significantly lagging earnings.
공시 • Nov 18The9 Limited, Annual General Meeting, Dec 19, 2022The9 Limited, Annual General Meeting, Dec 19, 2022, at 14:00 China Standard Time. Location: 17 Floor, No. 130 Wu Song Road, Hong Kou District Shanghai China
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. CFO & Director George Lai was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • May 04Full year 2021 earnings releasedFull year 2021 results: Revenue: CN¥135.9m (up CN¥135.2m from FY 2020). Net loss: CN¥411.2m (down 204% from profit in FY 2020).
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. CFO & Director George Lai was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Apr 15Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. CFO & Director George Lai was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공시 • Jun 05The9 Limited (NasdaqCM:NCTY) signed a definitive agreement to acquire an unknown stake in Montcrypto Ltd.The9 Limited (NasdaqCM:NCTY) signed a definitive agreement to acquire an unknown stake in Montcrypto Ltd. on June 4, 2021. According to the agreement, The9 plans to invest a total of CAD 7.6 million in Montcrypto in two phases to obtain the controlling stake in Montcrypto. The9 will pay hosting fee to Montcrypto at a rate of CAD 0.037/kWh for a period of 5 years.
공시 • Mar 10The9 Limited to Report Fiscal Year 2020 Results on Mar 29, 2021The9 Limited announced that they will report fiscal year 2020 results on Mar 29, 2021
공시 • Feb 23The9 Limited (NasdaqCM:NCTY) entered into a binding memorandum of understanding to acquire 70% stake in Hangzhou SuanLi Technology Co., Ltd. for $7 million.The9 Limited (NasdaqCM:NCTY) entered into a binding memorandum of understanding to acquire 70% stake in Hangzhou SuanLi Technology Co., Ltd. for $7 million on February 22, 2021. The consideration will be paid by issuing Class A ordinary shares of The9 Limited, subject to due diligence and valuation to be conducted by an independent valuation firm.
공시 • Feb 10The9 Limited Enters into a Standby Equity Distribution Agreement with YA II PN, LTDThe9 Limited announced that it has entered into a standby equity distribution agreement with YA II PN, LTD., dated February 5, 2021, pursuant to which The9 would be able to sell up to $100.0 million of its ADSs solely at The9’s request based on The9’s funding requirement at any time during the 36 months following the date of the SEDA.
공시 • Nov 21The9 Limited, Annual General Meeting, Dec 22, 2020The9 Limited, Annual General Meeting, Dec 22, 2020, at 14:00 China Standard Time. Location: at the 17 Floor, No. 130 Wu Song Road, Hong Kou District Shanghai China
공시 • Nov 18The9 Limited Announces Receipt of Nasdaq Notice of DeficiencyThe9 Limited announced on November 17, 2020 that it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market Inc. ("Nasdaq") dated November 12, 2020, indicating that the Company no longer meets the continued listing requirement of minimum Market Value of Listed Securities ("MVLS") for the Nasdaq Capital Market, as set forth in the Nasdaq Listing Rule 5550(b)(2) because the market value of the Company's securities listed on Nasdaq for the last 30 consecutive business days was below the minimum MVLS requirement of $35.0 million. Pursuant to the Rule 5810(c)(3)(C) of the Nasdaq Listing Rules, the Company has a compliance period of 180 calendar days, or until May 11, 2021 (the "Compliance Period"), to regain compliance with Nasdaq's minimum MVLS requirement. If at any time during the Compliance Period, the Company's MVLS closes at $35.0 million or more for a minimum of ten consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed. In the event the Company does not regain compliance with Rule 5550(b)(2) prior to the expiration of the Compliance Period, the Company will receive written notification that its securities are subject to delisting.
공시 • Nov 05The9 Limited Regains Compliance with Nasdaq Listing RequirementThe9 Limited announced that it received a notification letter from the Nasdaq Stock Market LLC ("Nasdaq") on November 2, 2020 stating that The9 has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) and the matter is now closed.
공시 • Oct 02The9 Limited has completed a Follow-on Equity Offering.The9 Limited has completed a Follow-on Equity Offering. Security Name: American Depositary Shares Security Type: Depositary Receipt (Common Stock) Securities Offered: 23,500,000 Price\Range: $0.37 Discount Per Security: $0.0259 Security Name: Warrants Security Type: Equity Warrant Securities Offered: 23,500,000
공시 • Oct 01The9 Limited announced that it expects to receive $30 million in funding from Ark Pacific Capital Management Limited, IE LimitedThe9 Limited (NasdaqGS:NCTY) announced that it has entered into a term sheet for the private placement of 25,000,000 ordinary shares at a price of $1.2 per share for gross proceeds of $30,000,000 on April 10, 2017. The transaction will include participation from existing investor Ark Pacific Special Opportunities Fund I, L.P., a fund managed by Ark Pacific Capital Management Limited and IE Limited (KOSDAQ:A023430). Each investor will subscribe for 50% of the total shares. The shares will be subject to a redemption right. The completion of the each transaction is subject to the parties execution of a definitive agreement and customary closing conditions to be stipulated therein.
공시 • Sep 22The9 Limited and Voodoo Sign Cooperation and Publishing AgreementThe9 Limited announced that it has signed an Agreement with Voodoo. The9 and Voodoo will collaborate on the publishing and operation of casual games in mainland China. The9 will publish and operate under this agreement two, with an option for a third, casual games with strong IAP (In App Purchase) licensed by Voodoo.
공시 • Aug 07The9 Limited Regains Compliance with Nasdaq Listing RequirementThe9 Limited announced that it received a notification letter from the Nasdaq Stock Market LLC ("Nasdaq") on August 5, 2020 stating that The9 has regained compliance with the minimum market value of listed securities requirement under Nasdaq Listing Rule 5550(b)(2) and the matter is now closed.